Entrinsic Bioscience Announces Breakthrough Innovation for Next Generation Sports and Recreational Rehydration™ Beverages
Entrinsic Bioscience has published a ground-breaking clinical study demonstrating the potential for next-generation sports and rehydration beverages, powered by its new Ultra-Hydrating HeatDefense™ formula which promotes dual action rapid rehydration with new levels of heat protection during sports, physical exertion and high heat stress.
Genascence to Present Full Data from Phase 1 Clinical Trial on GNSC-001, Company’s Lead Program in Osteoarthritis, at European Society of Gene & Cell Therapy 30th Annual Congress
Genascence Corporation, a clinical-stage biotechnology company revolutionizing the treatment of prevalent musculoskeletal diseases with gene therapy using technology discovered at the University of Florida, announced that data from the Phase 1 clinical trial of GNSC-001 for the treatment of osteoarthritis (OA) demonstrated that it was safe and well tolerated.
UF Health Cancer Center Researchers Receive UF Invention of the Year Awards
The UF Health Cancer Center team of Christian Jobin, Ph.D., and Rachel Newsome was honored with an Invention of the Year award from UF Innovate for their work identifying gut biome bacteria that can make lung cancer tumors responsive to immunotherapy treatment.
Innovators Celebrated, Inventions Showcased at Event by UF Innovate’s Tech Licensing
Tables with up-and-coming inventions that include an environment-scanning robot and augmented reality goggles lined the UF Innovate Tech Licensing organization’s sixth annual Standing InnOvation event this week.
Dr. Shannon Boye Named Innovator of the Year
UF Innovate | Tech Licensing hosted its sixth annual Standing InnOvation event on Wednesday, October 18, to honor and celebrate innovators and their work at the University of Florida in fiscal year 2023.
New Study Points to Concerns of Dangerous Vibrio Bacteria in Florida’s Coastal Waters Following Hurricane Ian
When Hurricane Ian struck Southwest Florida in September 2022, it unleashed a variety of Vibrio bacteria that can cause illness and death in humans, according to a new study conducted in October 2022 by researchers at the University of Florida and the University of Maryland, based on genome sequencing as well as satellite and environmental data collected off the coast of Lee County, where Hurricane Ian hit directly.
Dr. Shannon Boye Named Innovator of the Year
UF Innovate | Tech Licensing hosted its sixth annual Standing InnOvation event on Wednesday, October 18, to honor and celebrate innovators and their work at the University of Florida in fiscal year 2023.
“The Horse’s Mouth” with Enrico Levi of Inzecto
The Horse’s Mouth is a talk show where Tom McManus’s guests sidle up to his bar to discuss the intersection of sports, business, and life. Today, Tom sits with Enrico Levi of Inzecto, a UF startup licensing mosquito control technology created by Levi, Roberto Pereira, and principal investigator Philip Koehler at the UF College of Agriculture and Food Sciences.
Cannabix’s MSBS Marijuana Breathalyzer Technology Advances Quantification of THC in Breath
UF startup Cannabix Technologies Inc., developer of marijuana and alcohol breath testing devices, reported its Mass Spectrometer Breath Sampler technology along with the Breath Collection Unit have been used to quantify delta-9 THC levels from smoking and edibles in humans.
Capsida Biotherapeutics Enters Strategic Collaboration With Kate Therapeutics to Manufacture KateTx’s Next-Generation Gene Therapies
Capsida Biotherapeutics Inc. and UF startup Kate Therapeutics announced a strategic partnership to leverage Capsida's expertise and adeno-associated virus (AAV) manufacturing capabilities to enable KateTx's initial internal portfolio of muscle and heart disease programs.
